Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$320,601
New position
Shares Held
49,552
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 28%
Shared 0%
None 72%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026IEQ CAPITAL, LLC holds $139,775,851 across 17 Drug Manufacturers - Specialty & Generic names. TLRY ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
765,982 | $100,910,468 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
35,915 | $21,296,876 | |
| 3 | ZTS |
Zoetis Inc.
|
31,568 | $3,731,652 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
742,723 | $2,606,957 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
42,950 | $2,068,042 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
104,316 | $1,931,932 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
130,069 | $1,801,455 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
42,533 | $1,281,093 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $320,601 | 49,552 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||